MDClone raises $63M for health data startup and more digital health funding

Company health data MDClone announced a $63 million Series C financing round. This news comes two and a half years after the Israeli company announced its news $26 million Series B. Warburg Pincus and Viola Growth led the round, with participation from aMoon, LightSpeed ​​Venture Partners and OrbiMed.

The startup has created a self-service data analytics platform designed to help health systems access and organize their data. The system was created to help customers find data insights that aid medical research and patient outcomes.

Customers can ask the platform to create patient cohorts, grouping patients by each event on a patient’s timeline. The platform also lets users see productivity over time. It may also use synthetic data to share information from other organizations.

The company plans to expand its services into new regional markets and expand its platform. It is also seeking new markets in the life sciences and real-world evidence space.

“We had been looking to invest in the digital health space for some time and were fascinated by MDClone and the tremendous opportunity it presents to healthcare by democratizing health data without risking exposing individuals’ data. amazing results shown progress over the past year and an even bigger vision that we believe can change the way doctors around the world can treat patients and improve care,” said Eran Westman, general partner at Viola Growth.


Navigational aid for health benefits Nayya announced a $55 million Series C financing round led by ICONIQ Growth. This news comes less than a year after the New York-based company issued a Series B round of $37 million.

The platform aims to help employees choose their insurance plans and then make the most of the plan. It uses AI and data science to provide users with personalized recommendations for selecting a plan. It also helped users figure out the best ways to save money.

The company plans to use the cash infusion for product innovation and new partnerships.

“Over the past two years, there has been a dramatic increase in anxiety, loneliness and depression among countless individuals, dramatically changing the lives of workers in various industries,” Sina Chehrazi, co-founder and CEO of Nayya, said in a statement.

“That’s why it’s so vital for organizations to offer high-quality, personalized benefits and coverage plans to empower a dynamic, creative and engaged workforce. This investment is a vote of confidence in our mission to make healthcare and benefits clearer, faster, friendlier, much cheaper and cheaper.”


Synapse Medicine, a French startup focused on helping doctors prescribe the best medication, scored $28 million in a funding round led by Korelya Capital, with participation from XAnge, MACSF and BNP Paribas Development. This new investment brings the company’s total revenue to $40 million.

The company’s platform provides clinicians with up-to-date independent information about drugs. It also helps to coordinate care with other prescribers. The service comes with a personal assistant that allows users to analyze their prescription and search for drug labeling. It also helps patients communicate with doctors.

The new investment will go towards scaling the platform in the US and Europe.


Full-stack Canadian digital health company Curv Health announced a C. at$5.1 million seed funding round led by iGan Partners and Build Ventures. Kale Investment Fund, Globalive Capital and NewFund Capital also participated in this financing round.

Patients can use Curv for care navigation services and care plan management. Curv works with employers and health insurers to connect members and health care providers. The company is active in physical, nutritional and mental health care.

“At the heart of the Curv platform is a suite of digital tools that act as the ‘connective tissue’ between service providers and customers. These tools enable new pathways of care that use automation to reduce the resources needed to achieve optimal outcomes, said Shea Balish, CEO of Curv Health.

“At the same time, these efficient care pathways help independent healthcare providers grow their practice and revenues rapidly.”

Curv plans to use the money for product development and to take on new features.